Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Adalimumab

Diarrhoea and sepsis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Ayabe R, et al. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plastic and Reconstructive Surgery 30: 415-419, No. 5, Jan 2014 - USACrossRefPubMed Ayabe R, et al. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plastic and Reconstructive Surgery 30: 415-419, No. 5, Jan 2014 - USACrossRefPubMed
Metadaten
Titel
Adalimumab
Diarrhoea and sepsis: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1783-3

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Herbal medicines

Case report

Rituximab